재발성 결절앞공막염에서 유리체강 내 덱사메타손 임플란트의 효과
Effect of Intravitreal Dexamethasone Implant Injection in a Patient with Recurrent Nodular Anterior Scleritis
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

Case summary: A 16-year-old patient presented with persistent eye pain and conjunctival injection in the left eye, which were diagnosed as nodular anterior scleritis. The clinical features improved with topical and systemic steroid treatment, but the patient developed side effects related to steroid use, including elevated intraocular pressure and skin rash. The steroid dose was reduced which led to frequent recurrence. Immunosuppressive agents were added to the treatment regimen, but there was no improvement; the patient developed intermediate uveitis and vitreous hemorrhage. Scleritis and intermediate uveitis continued despite vitrectomy; therefore, intravitreal dexamethasone implant injection was performed. There was no scleritis recurrence within 1 year after injection, which allowed tapering of steroids and immunosuppressive drugs. Conclusions: Intravitreal dexamethasone implant injection may be effective for recurrent nodular anterior scleritis in patients who exhibit complications, such as intermediate uveitis. © 2023 The Korean Ophthalmological Society.

키워드

Immunosuppressive agentsIntravitreal injectionScleritisSteroid
제목
재발성 결절앞공막염에서 유리체강 내 덱사메타손 임플란트의 효과
제목 (타언어)
Effect of Intravitreal Dexamethasone Implant Injection in a Patient with Recurrent Nodular Anterior Scleritis
저자
Kwon, L.-H.Kim, S.-J.
DOI
10.3341/JKOS.2023.64.3.252
발행일
2023-03
유형
Article
저널명
대한안과학회지
64
3
페이지
252 ~ 255